Canaccord Genuity reiterated their buy rating on shares of Synthomer (LON:SYNT) in a research report released on Monday. They currently have a GBX 575 ($7.51) price objective on the stock.
Several other equities analysts have also issued reports on SYNT. Numis Securities reiterated a hold rating on shares of Synthomer in a research report on Monday, July 30th. Peel Hunt reiterated a buy rating and issued a GBX 690 ($9.02) price objective (up from GBX 670 ($8.75)) on shares of Synthomer in a research report on Friday, August 3rd. JPMorgan Chase & Co. reiterated a neutral rating on shares of Synthomer in a research report on Tuesday, August 7th. Deutsche Bank boosted their price objective on Synthomer from GBX 630 ($8.23) to GBX 640 ($8.36) and gave the company a buy rating in a research report on Tuesday, August 7th. Finally, UBS Group reiterated a sell rating on shares of Synthomer in a research report on Tuesday, August 7th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus price target of GBX 525 ($6.86).
Shares of SYNT opened at GBX 446.20 ($5.83) on Monday. Synthomer has a 52-week low of GBX 452.51 ($5.91) and a 52-week high of GBX 517.50 ($6.76).
The company also recently announced a dividend, which will be paid on Tuesday, November 6th. Shareholders of record on Thursday, October 4th will be paid a GBX 4 ($0.05) dividend. This represents a yield of 0.74%. The ex-dividend date is Thursday, October 4th.
Synthomer plc operates as a specialty chemical company in Europe, North America, Asia, and internationally. It offers adhesives for use in labels, graphics, specialty tapes, caulks and sealants, wet glues, protective films, packaging, and other applications; and high solid lattices for foamed footwear and bedding products.
See Also: What is the NASDAQ?
Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.